Search Results 341-350 of 17272 for peptide protocols

1. Chronic Nausea And Vomiting In Patients With Normal Gastric Emptying Using The Enterra® Therapy System - Mayo Clinic

   Sponsor Protocol Number: NAVIGATE ENT-CL-5000 ... Guidelines differ from study to study, and identify who can or cannot participate. ... Glucagon-like peptide 1 ( ...

2. A Study to Better Understand if Diet and Metabolism are Connected with MS Relapses and Disease Progress in Patients with Pediatric-onset MS - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

3. A Study to Evaluate the Nrf2 Response in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

4. Clinical trials - Oncology (Medical)

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

5. Gastroenterology and Hepatology - Clinical trials

   The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol.

6. Clinical trials - Oncology (Medical)

   This protocol allows multiple treatments with TheraSphere® that may be ... protocol survivor follow up) in patients with advanced non-ocular melanoma.

7. Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Oversight Control in Type 1 Diabetes - Mayo Clinic

   This protocol will test the feasibility of ... Guidelines differ from study to study, and identify who can or cannot participate. ... Any medication being taken to ...

8. A Study to Examine Diabetes Control and Patient Reported Outcomes Among Kidney Transplant Recipients with Type 2 Diabetes - Mayo Clinic

   Guidelines differ from study to study, and identify who can or cannot participate. ... Positive C peptide (>2.0 ng/ml)at any time and/or clinically verified T2DM ...

9. Clinical trials - Oncology (Medical)

   The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of MEDI- ...

10. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...